P3.03I.10 RRAS and RRAS2 Mutations Are Oncogenic Drivers in Lung Cancer and are Sensitive to the Pan-RAS Inhibitor RMC-6236

Autor: Pfeil, A.J., Zhang, T., Febres-Aldana, C.A., Cheng, R., Mattar, M.S., Arbour, K., Ladanyi, M., Yang, S.-R., Somwar, R.
Zdroj: Journal of Thoracic Oncology; October 2024, Vol. 19 Issue: 10, Number 10 Supplement 1 pS313-S313, 1p
Databáze: Supplemental Index